ArticleOncotarget2017

Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy.

Mary Jo Fidler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.